Prognostic assessment of the Japanese Renal Pathology Society classification in Chinese patients with histologically confirmed diabetic kidney disease

Ying Shi, Yuyu Ye, Qian Zhou, Hujia Hua, Yanggang Yuan, Chengning Zhang, Mao Huijuan, Suyan Duan, Bo ZhangClinical 2025 · DOI

TL;DR

This study investigated the prognostic value of the Japanese Renal Pathology Society (JRPS) classification for predicting diabetic kidney disease (DKD) progression in Chinese patients. While the JRPS classification showed an association with adverse renal outcomes, it performed less effectively than the traditional Renal Pathology Society (RPS) classification in predicting these outcomes, suggesting it may be a complementary tool rather than a primary prognostic indicator.

What Problem Does This Paper Address?

Diabetic kidney disease (DKD) is a major complication of diabetes, leading to end-stage kidney disease (ESKD) and significantly increasing cardiovascular morbidity and mortality. Accurately predicting the progression of DKD is crucial for timely intervention and personalized patient management. Pathological classification of kidney biopsies plays a key role in this assessment. The traditional Renal Pathology Society (RPS) classification primarily focuses on glomerular changes. However, research suggests that tubulointerstitial and vascular lesions also significantly contribute to DKD progression. To address this, the Japanese Renal Pathology Society (JRPS) developed a more comprehensive classification system (J-score) that includes these additional factors. This study aimed to evaluate the prognostic value of this newer JRPS classification in a Chinese DKD cohort and compare its performance against existing systems.

Methods

This was a retrospective cohort study involving 124 patients diagnosed with DKD between 2014 and 2020. Patients' kidney biopsy specimens were classified using the JRPS system, with J-scores used to categorize patients into four grades. The study also assessed the traditional RPS glomerular classification and a "total renal chronicity score" system. Renal survival was analyzed using Kaplan-Meier curves and Cox regression. To compare the predictive accuracy of the different classification systems, receiver operating characteristic (ROC) curve analysis and the DeLong test were employed.

Datasets

The study utilized a dataset of 124 patients with biopsy-proven diabetic kidney disease from the First Affiliated Hospital with Nanjing Medical University. Clinical and pathological data were collected retrospectively from electronic medical records and kidney biopsy specimens. No new benchmark datasets were introduced.

Key Insights and Ideas

  • JRPS captures broader pathology: The JRPS classification system is designed to be more comprehensive, incorporating not only glomerular but also tubulointerstitial and vascular lesions, offering a more holistic view of renal damage in DKD.
  • Association with adverse outcomes: Higher JRPS classification grades were independently associated with a greater risk of adverse renal outcomes, including progression to ESKD and doubling of serum creatinine.
  • RPS still leads in prediction: Despite its broader scope, the JRPS classification demonstrated inferior discriminatory performance for predicting renal outcomes compared to the traditional RPS glomerular classification.
  • Complementary role: The findings suggest that the JRPS classification might provide valuable complementary pathological information rather than serving as a standalone primary prognostic tool. It can enhance the contextual interpretation of traditional glomerular-based evaluations.

Key Results

Over a median follow-up of 37 months, 76.6% of patients experienced renal outcomes, with 40.3% progressing to ESKD. Kaplan-Meier analysis showed a significant increase in the cumulative incidence of primary renal outcomes with higher JRPS classification grades (log-rank P=0.003). Multivariate Cox regression confirmed that higher JRPS classification grades were independently associated with adverse renal outcomes. However, ROC analysis revealed that the RPS glomerular classification had a significantly superior predictive performance (AUC=0.892) compared to the JRPS classification grade (AUC=0.690) and the J-score (AUC=0.784).

Limitations and Future Work

The authors acknowledge several limitations:

  • Single-center retrospective study: This limits the generalizability of the findings.
  • Small sample size: The cohort of 124 patients may not be representative of the broader DKD population.
  • Lack of interobserver reproducibility assessment: This is crucial for validating the robustness of pathological scoring.
  • Incomplete data on newer therapies: The study period meant data on newer agents like SGLT2 inhibitors were incomplete, potentially influencing outcomes.

Future work should involve:

  • Larger, prospective cohorts: To validate the findings and improve generalizability.
  • Integration of biomarkers: Combining pathological findings with clinical biomarkers and systemic markers for better cardiovascular risk prediction.
  • Exploring emerging approaches: Investigating the use of artificial intelligence for more comprehensive prognostic models.
  • Considering genetic, lifestyle, and environmental factors: These may also play a role in DKD progression.

Summary updated

Abstract

The JRPS classification was independently associated with renal outcomes but showed inferior discriminatory performance compared with the RPS classification. These findings suggest that JRPS classification may provide complementary pathological information rather than serving as a primary prognostic tool.
BibTeX
@inproceedings{shi2025prognostic,
  author = {Ying Shi and Yuyu Ye and Qian Zhou and Hujia Hua and Yanggang Yuan and Chengning Zhang and Mao Huijuan and Suyan Duan and Bo Zhang},
  title = {{Prognostic assessment of the Japanese Renal Pathology Society classification in Chinese patients with histologically confirmed diabetic kidney disease}},
  booktitle = {Clinical},
  year = {2025},
  doi = {10.1007/s10157-025-02782-w},
}
Figure